Range
1.33 - 1.37
Vol / Avg.
199.1K/531.2K
Div / Yield
-
52 Wk
1.25 - 4.89
Mkt Cap
79.1M
Payout Ratio
-
Open
1.35
P/E
-
EPS
-0.19
Shares
59.5M
Outstanding
59.5M
Total Float
58.8M
load more
Sector: Health Care.Industry: Biotechnology
Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company developing cellular therapies designed to reverse, not manage, disease. The company's product candidates include: CLBS119, for the repair of lung damage found in patients with severe COVID-19 infection who experienced respiratory failure, clinical trial to be initiated in 3Q2020 (USA); CLBS12, recipient of a SAKIGAKE (Japan) and ATMP (Europe) designations, eligible for early conditional approval for the treatment of critical limb ischemia based on an ongoing clinical trial (Japan); CLBS16, subject of the completed proof-of-concept ESCaPE-CMD clinical and planned Phase 2B (U.S.A.); and CLBS14, a Phase 3 ready clinical program in no option refractory disabling angina and recipient of a RMAT designation (USA).

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.080-0.190 -0.1100
REV660.000K0-660.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CLBSCaladrius Biosciences-1.48%79.1M

Caladrius Biosciences Frequently Asked Questions

Q

How do I buy Caladrius Biosciences (CLBS) stock?

A

You can purchase shares of Caladrius Biosciences (NASDAQ: CLBS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Caladrius Biosciences's (CLBS) competitors?

Q

What is the target price for Caladrius Biosciences (CLBS) stock?

A

The latest price target for Caladrius Biosciences (NASDAQ: CLBS) was reported by Brookline Capital on March 3, 2021. The analyst firm set a price target for 10.00 expecting CLBS to rise to within 12 months (a possible 651.88% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Caladrius Biosciences (CLBS)?

A

The stock price for Caladrius Biosciences (NASDAQ: CLBS) is $1.33 last updated Fri Jul 30 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Caladrius Biosciences (CLBS) pay a dividend?

A

There are no upcoming dividends for Caladrius Biosciences.

Q

When is Caladrius Biosciences (NASDAQ:CLBS) reporting earnings?

A
Caladrius Biosciences’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Caladrius Biosciences (CLBS) going to split?

A

There is no upcoming split for Caladrius Biosciences.

Q

What sector and industry does Caladrius Biosciences (CLBS) operate in?

A

Caladrius Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.